Lew Jennifer

Lew Jennifer is listed in filings as Director at Boundless Bio, Inc.. This profile follows SEC Form 4 activity through Jun 15, 2026, including sale activity. Recent filings connect the profile to Boundless Bio, Inc. (BOLD) and Annexon, Inc. (ANNX). The current snapshot covers public activity from Jul 17, 2024 to Jun 15, 2026. Reported amounts are shown as $44.8K to $6.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.